Trial · NCT01499368
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Recovery Rates of Reflux Esophagitis | Lafutidine | Recovered | 101 | Participants | |
| Recovery Rates of Reflux Esophagitis | Famotidine | Recovered | 92 | Participants | |
| Recovery Rates of Reflux Esophagitis | Omeprazole | Recovered | 126 | Participants | |
| Recovery Rates of Reflux Esophagitis | Lafutidine | Not recovered | 43 | Participants | |
| Recovery Rates of Reflux Esophagitis | Famotidine | Not recovered | 53 | Participants | |
| Recovery Rates of Reflux Esophagitis | Omeprazole | Not recovered | 21 | Participants | |
| The Proportion of Days Without 'Cardinal Symptom' | Lafutidine | week 4 | 0.64 | Standard Deviation 0.31 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Famotidine | week 4 | 0.56 | Standard Deviation 0.32 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Omeprazole | week 4 | 0.69 | Standard Deviation 0.30 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Lafutidine | week 8 | 0.77 | Standard Deviation 0.27 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Famotidine | week 8 | 0.67 | Standard Deviation 0.32 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Omeprazole | week 8 | 0.82 | Standard Deviation 0.24 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Lafutidine | week 8(LOCF) | 0.77 | Standard Deviation 0.27 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Famotidine | week 8(LOCF) | 0.67 | Standard Deviation 0.32 | proportion of days |
| The Proportion of Days Without 'Cardinal Symptom' | Omeprazole | week 8(LOCF) | 0.82 | Standard Deviation 0.24 | proportion of days |
| The Proportion of Daytimes Without 'Cardinal Symptom' | Lafutidine | week 4 | 0.74 | Standard Deviation 0.27 | proportion of days |
| The Proportion of Daytimes Without 'Cardinal Symptom' | Famotidine | week 4 | 0.68 | Standard Deviation 0.29 | proportion of days |
| The Proportion of Daytimes Without 'Cardinal Symptom' | Omeprazole | week 4 | 0.77 | Standard Deviation 0.27 | proportion of days |
| The Proportion of Daytimes Without 'Cardinal Symptom' | Lafutidine | week 8 | 0.83 | Standard Deviation 0.23 | proportion of days |
| The Proportion of Daytimes Without 'Cardinal Symptom' | Famotidine | week 8 | 0.76 | Standard Deviation 0.28 | proportion of days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01499368/results